Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)

Market Cap	59.13B +2.6%
Revenue (ttm)	42.31B +4.9%
Net Income	3.48B +18.9%
EPS	1.31 +19.4%
Shares Out	2.64B
PE Ratio	18.47
Forward PE	19.67
Dividend	0.39 (1.56%)
Ex-Dividend Date	Aug 4, 2025

Volume	7,142,701
Average Volume	19,204,621
Open	24.10
Previous Close	24.19
Day's Range	23.96 - 24.24
52-Week Range	23.42 - 33.10
Beta	0.41
RSI	31.19
Earnings Date	Apr 28, 2026

About SHA:600196

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company of...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 40,603
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600196

Financial Performance

In 2025, SHA:600196's revenue was 41.66 billion, an increase of 1.45% compared to the previous year's 41.07 billion. Earnings were 3.37 billion, an increase of 21.69%.